Vanguard Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $9.58B | Buy |
120,709,530
+1,824,424
| +2% | +$144M | 0.14% | 117 |
|
|
2025
Q3 | $8.96B | Sell |
118,885,106
-1,514,025
| -1% | -$104M | 0.13% | 128 |
|
|
2025
Q2 | $8.31B | Buy |
120,399,131
+2,063,737
| +2% | +$135M | 0.13% | 133 |
|
|
2025
Q1 | $8.02B | Buy |
118,335,394
+969,027
| +0.8% | +$58M | 0.14% | 119 |
|
|
2024
Q4 | $5.27B | Sell |
117,366,367
-250,065
| -0.2% | -$14M | 0.09% | 190 |
|
|
2024
Q3 | $7.4B | Buy |
117,616,432
+1,266,310
| +1% | +$73.9M | 0.13% | 131 |
|
|
2024
Q2 | $6.87B | Buy |
116,350,122
+232,632
| +0.2% | +$14.6M | 0.13% | 130 |
|
|
2024
Q1 | $9.26B | Sell |
116,117,490
-1,578,795
| -1% | -$121M | 0.18% | 96 |
|
|
2023
Q4 | $9.29B | Buy |
117,696,285
+533,659
| +0.5% | +$38M | 0.2% | 83 |
|
|
2023
Q3 | $8.18B | Buy |
117,162,626
+485,744
| +0.4% | +$34.4M | 0.2% | 88 |
|
|
2023
Q2 | $8.07B | Buy |
116,676,882
+341,411
| +0.3% | +$24.3M | 0.19% | 89 |
|
|
2023
Q1 | $8.64B | Sell |
116,335,471
-1,197,901
| -1% | -$100M | 0.22% | 81 |
|
|
2022
Q4 | $11B | Buy |
117,533,372
+1,598,531
| +1% | +$154M | 0.3% | 61 |
|
|
2022
Q3 | $11.1B | Buy |
115,934,841
+1,726,512
| +2% | +$171M | 0.33% | 47 |
|
|
2022
Q2 | $10.6B | Buy |
114,208,329
+2,342,667
| +2% | +$229M | 0.3% | 58 |
|
|
2022
Q1 | $11.3B | Buy |
111,865,662
+2,628,740
| +2% | +$276M | 0.27% | 63 |
|
|
2021
Q4 | $11.3B | Buy |
109,236,922
+879,616
| +0.8% | +$81.3M | 0.26% | 66 |
|
|
2021
Q3 | $9.2B | Buy |
108,357,306
+861,567
| +0.8% | +$72.2M | 0.23% | 77 |
|
|
2021
Q2 | $8.97B | Buy |
107,495,739
+1,170,549
| +1% | +$95.9M | 0.22% | 77 |
|
|
2021
Q1 | $8B | Buy |
106,325,190
+941,267
| +0.9% | +$68.6M | 0.22% | 77 |
|
|
2020
Q4 | $7.2B | Sell |
105,383,923
-773,094
| -0.7% | -$50.3M | 0.21% | 79 |
|
|
2020
Q3 | $6.2B | Sell |
106,157,017
-1,050,300
| -1% | -$65.4M | 0.21% | 83 |
|
|
2020
Q2 | $6.97B | Sell |
107,207,317
-531,433
| -0.5% | -$33.5M | 0.25% | 71 |
|
|
2020
Q1 | $6.39B | Buy |
107,738,750
+2,930,548
| +3% | +$196M | 0.27% | 67 |
|
|
2019
Q4 | $7.79B | Buy |
104,808,202
+1,399,688
| +1% | +$98.3M | 0.27% | 66 |
|
|
2019
Q3 | $6.52B | Buy |
103,408,514
+1,040,615
| +1% | +$61.7M | 0.24% | 69 |
|
|
2019
Q2 | $5.58B | Buy |
102,367,899
+1,167,143
| +1% | +$62.9M | 0.21% | 80 |
|
|
2019
Q1 | $5.46B | Sell |
101,200,756
-8,012,696
| -7% | -$495M | 0.21% | 82 |
|
|
2018
Q4 | $7.16B | Buy |
109,213,452
+24,339,638
| +29% | +$1.82B | 0.32% | 56 |
|
|
2018
Q3 | $6.68B | Buy |
84,873,814
+1,445,887
| +2% | +$103M | 0.26% | 70 |
|
|
2018
Q2 | $5.37B | Buy |
83,427,927
+4,892,512
| +6% | +$322M | 0.22% | 76 |
|
|
2018
Q1 | $4.89B | Sell |
78,535,415
-43,392
| -0.1% | -$3.11M | 0.21% | 81 |
|
|
2017
Q4 | $5.7B | Buy |
78,578,807
+1,046,397
| +1% | +$76.1M | 0.25% | 69 |
|
|
2017
Q3 | $6.3B | Buy |
77,532,410
+974,813
| +1% | +$77.1M | 0.29% | 56 |
|
|
2017
Q2 | $6.16B | Buy |
76,557,597
+1,056,265
| +1% | +$83.4M | 0.3% | 53 |
|
|
2017
Q1 | $5.93B | Buy |
75,501,332
+1,120,254
| +2% | +$89.4M | 0.3% | 51 |
|
|
2016
Q4 | $5.87B | Buy |
74,381,078
+1,352,472
| +2% | +$109M | 0.33% | 47 |
|
|
2016
Q3 | $6.5B | Buy |
73,028,606
+1,483,616
| +2% | +$140M | 0.38% | 44 |
|
|
2016
Q2 | $6.85B | Buy |
71,544,990
+15,979
| +0% | +$1.59M | 0.43% | 42 |
|
|
2016
Q1 | $7.42B | Buy |
71,529,011
+2,578,178
| +4% | +$251M | 0.48% | 35 |
|
|
2015
Q4 | $6.74B | Buy |
68,950,833
+1,086,137
| +2% | +$106M | 0.45% | 39 |
|
|
2015
Q3 | $6.55B | Sell |
67,864,696
-45,257
| -0.1% | -$4.76M | 0.47% | 33 |
|
|
2015
Q2 | $7.12B | Buy |
67,909,953
+671,875
| +1% | +$68.6M | 0.48% | 32 |
|
|
2015
Q1 | $6.94B | Sell |
67,238,078
-817,733
| -1% | -$82.7M | 0.47% | 34 |
|
|
2014
Q4 | $6.55B | Buy |
68,055,811
+1,185,384
| +2% | +$104M | 0.47% | 35 |
|
|
2014
Q3 | $5.32B | Buy |
66,870,427
+658,343
| +1% | +$51.9M | 0.41% | 38 |
|
|
2014
Q2 | $4.99B | Buy |
66,212,084
+786,789
| +1% | +$59.5M | 0.39% | 40 |
|
|
2014
Q1 | $4.9B | Buy |
65,425,295
+8,938,722
| +16% | +$631M | 0.41% | 39 |
|
|
2013
Q4 | $4.04B | Sell |
56,486,573
-743,769
| -1% | -$47.8M | 0.36% | 47 |
|
|
2013
Q3 | $3.25B | Buy |
57,230,342
+1,471,543
| +3% | +$87.7M | 0.32% | 51 |
|
|
2013
Q2 | $3.19B | Buy |
+55,758,799
| New | +$3.23B | 0.33% | 48 |
|
Other funds holding CVS
Vanguard Group's CVS Position: Q4 2025 in Review
Vanguard Group increased its CVS Health (CVS) stake by 1.5% in Q4 2025, buying an estimated $144M and bringing the position to 120,709,530 shares worth $9.58B. The position accounts for 0.14% of the portfolio, ranked #117.
Vanguard Group first reported a position in CVS in Q2 2013 and has held it in 51 quarters since. The position peaked at $11.3B in Q1 2022. 1,946 funds tracked by Wall St. Rank hold CVS as of Q4 2025.
- Vanguard Group held 120,709,530 shares of CVS Health worth $9.58B as of Q4 2025.
- Vanguard Group bought 1,824,424 CVS Health shares in Q4 2025, an estimated $144M.
- CVS Health made up 0.14% of Vanguard Group's portfolio in Q4 2025, its #117 holding.
- Vanguard Group first reported a position in CVS Health in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's CVS Health position peaked at $11.3B in Q1 2022.
- 1,946 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.